Dr. Michael W. Ruff, MD

Dr. Ruff practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Ruff's NPI, 1649611260, was assigned on July 11, 2013. Dr. Ruff graduated from University of Missouri, Kansas City, School of Medicine in 2013. Dr. Ruff holds Minnesota license 58195.

Dr. Ruff's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Ruff's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. Dr. Ruff is also affiliated with Mayo Clinic Health System in La Crosse. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Ruff to 1 more hospital, 1 hospice, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ruff practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Ruff's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Ruff is licensed in Minnesota.

CMS data shows 267 Medicare services from Dr. Ruff across 6 procedure codes in 2024, for 158 Medicare patients. Medicare paid $30,392 for them. Every service was in an office.

CMS counts 158 Medicare patients who saw Dr. Ruff in 2024. The largest group is 65 to 74, with 80 patients. 58% of them have high cholesterol, and 56% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ruff's median patient age at 57, with 50% women.

In 2024, Dr. Ruff wrote 473 Medicare Part D claims for 94 patients. 90% of them were for generic drugs. CMS names the drug for 347 of them, across 13 drugs with 11 or more claims each, at $15,140 in total drug cost. In 2023, CMS named 289 claims across 8 drugs.

Dr. Ruff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ruff as offering telehealth.

Dmand AI links 64 papers to Dr. Ruff, published from 2012 to 2025. 2018 was the busiest year, with 8. The most frequent topics are Brain Neoplasms, Glioblastoma and Glioma. Dr. Ruff has published most often in Neurologist. Dr. Ruff's most frequent co-authors are Joon H. Uhm, MD, Sani Haider Kizilbash, MBBS and Bryan Joseph Neth, MD.

Dmand AI links Dr. Ruff to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Glioblastoma and Astrocytoma.

CMS Open Payments shows 6 general payments to Dr. Ruff from 2 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 89% of the total. Servier Pharmaceuticals LLC paid the most, $3,372.

Dr. Ruff graduated from University of Missouri, Kansas City, School of Medicine in 2013.